OXYTOCIN-ANALOGA

European patent · EP2260053 · In force

Register entry

Publication number
EP2260053
Application number
EP09727031
Kind
European patent with effect for Switzerland and Liechtenstein
Status
In force
Specification
Granted
Filed
Mar 30, 2009
Published
Dec 15, 2010
Granted
May 14, 2014
Protection ends at the latest
Mar 29, 2029
Next annual fee due
Mar 31, 2027
IPC classes
C07K 7/16 (2006.01)
Priority
US 40973 P 31.03.2008
EP 08251739 19.05.2008
PCT application
PCT/IB2009/005351 30.03.2009
PCT publication
WO2009/122285 08.10.2009
Filing language
English
Source
Swissreg

History

What the Federal Institute of Intellectual Property published about this title, newest first.

  1. Apr 1, 2026

    Change

    Published in Swissreg on 01.04.2026

  2. Apr 1, 2025

    Change

    Published in Swissreg on 01.04.2025

  3. Apr 1, 2024

    Change

    Published in Swissreg on 01.04.2024

  4. Apr 1, 2023

    Change

    Published in Swissreg on 01.04.2023

  5. May 24, 2014

    Agent entered

    Representative
    BOVARD AG, Patent- und Markenanwälte, Optingenstrasse 16, 3000 Bern 25

    Published in Swissreg on 24.05.2014

  6. May 14, 2014

    Granted

    Published in Swissreg on 14.05.2014

Parties

Holder

Ferring BV

Polaris Avenue 144, 2132 JX Hoofddorp, NL

Agent

Bovard AG

BOVARD AG

Patent- und Markenanwälte Optingenstrasse 16, 3000 Bern 25

Inventor

ALAGARSAMY, Sudarkodi

San Diego, CA 92109, US

GALYEAN, Robert

Cottonwood, CA 96022, US

WISNIEWSKI, Kazimierz

San Diego, CA 92127, US

SCHTEINGART, Claudio

San Diego, CA 92122, US

The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.